HPV DNA Test: what it checks, what your result means, and what to do next - Turkey

What exactly is the HPV DNA test?

The HPV DNA test is a laboratory test that looks for the genetic material of high-risk types of human papillomavirus in cells taken from the cervix or vagina. Unlike a test that looks at cell appearance, it detects the virus that causes cervical changes, often before any abnormality is visible. It is now used as a primary method of cervical cancer screening because a negative result gives strong reassurance that the risk of cervical cancer in the coming years is very low. In short, it answers a focused question — is a cancer-causing type of HPV present? — and guides what should happen next.

HPV DNA test or Pap smear — what's the difference?

The two tests are often confused, but they look for different things and increasingly work as a pair. A Pap smear (cytology) examines cervical cells under a microscope for changes that have already happened, while the HPV DNA test detects the virus that causes those changes, often earlier. The HPV test is more sensitive — it detects around 90 to 95 % of significant precancers, against roughly 55 to 70 % for cytology alone — which is why guidelines now prefer it as the primary screen for women aged 30 and over. The sample is collected the same way, so for you the experience is nearly identical; the difference is in what the laboratory measures.

Source: American College of Obstetricians and Gynecologists (ACOG), cervical cancer screening

What is HPV, and why does it matter?

Human papillomavirus (HPV) is a very common virus spread through skin and intimate contact, and most sexually active people encounter it at some point — by some estimates around 80 % over a lifetime. The great majority of infections cause no symptoms and clear on their own, with roughly 90 % gone within about two years through the body's own immune response. A small number of high-risk types, however, can persist and slowly cause changes in cervical cells. Because two types, HPV 16 and 18, cause about 70 % of cervical cancers — and a wider group of high-risk types accounts for around 90 % — testing for these specific types is what makes screening so effective.

Source: World Health Organization (WHO), cervical cancer and HPV

Who should be tested, and how often?

Screening recommendations depend mainly on age, and for most women the HPV DNA test is now the preferred option from age 30. Current guidance suggests cervical screening from age 21, with cytology every 3 years for women aged 21 to 29, and from age 30 to 65 a primary HPV test every 5 years (or co-testing with cytology every 5 years). The longer interval is safe precisely because a negative HPV test is so reassuring. These intervals apply to women at average risk; those with a previous abnormal result, a weakened immune system or other risk factors may need closer follow-up, which we tailor to you.

Source: U.S. Preventive Services Task Force (USPSTF), cervical cancer screening

How is the HPV DNA test done?

The test itself is quick and similar to a routine smear, taking only a minute or two. A clinician gently collects a small sample of cells from the cervix during a brief pelvic examination, and the sample is sent to the laboratory to check for high-risk HPV DNA. Self-collection of a vaginal sample is now an accepted option in many settings, although a clinician-collected sample is still preferred and a positive self-test is followed by a clinician-collected one. Most women feel only brief pressure, and light spotting afterwards is normal and settles quickly.

What does your HPV result mean?

An HPV result is more reassuring than many people expect, and understanding it removes much of the worry. A negative result means no high-risk HPV was found, giving a negative predictive value above 99 % — your risk of cervical cancer in the next few years is very low, which is why the next test can safely be years away. A positive result means a high-risk type is present, but on its own it is not a diagnosis of cancer or even of precancer; whether anything further is needed depends on the type found and any cell changes. We always explain your specific result in plain language so you know exactly what it does and does not mean.

I tested HPV positive — what happens next?

A positive result usually leads to a calm, stepwise follow-up rather than immediate treatment, and around 90 % of positive results never need any. Depending on the HPV type and whether cells look abnormal, the next step is often a colposcopy — a close look at the cervix with a magnifying instrument, sometimes with a small biopsy — or simply a repeat test after an interval to see whether the infection has cleared. If a precancerous change is confirmed, it can be treated effectively while it is still early. We guide this process so each step is understood and nothing is rushed or missed.

Common worries and misconceptions about HPV

Few test results carry as much unnecessary worry and stigma as HPV, so it helps to clear up the common myths plainly. A positive result does not mean cancer, does not mean a partner has been unfaithful, and does not say when the virus was acquired — HPV can stay silent for years. It is so common that having it is not a reason for blame or shame, and in most people the immune system clears it without any treatment. We mention this because anxiety and stigma lead some women to avoid testing altogether, which is the one choice that genuinely raises risk.

How does HPV lead to cervical cancer risk?

Cervical cancer develops slowly, over years, and only in the small share of people whose high-risk HPV infection persists rather than clears. Persistent high-risk HPV is found in more than 99 % of cervical cancers, yet only a minority of persistent infections, if left unmonitored, progress toward cancer over a long period. This slow timeline is exactly why screening works so well: there is usually a wide window to detect and treat changes early. With regular screening and treatment of any precancer, cervical cancer is largely preventable, and screening programmes have cut deaths from it substantially.

Source: American Society for Colposcopy and Cervical Pathology (ASCCP), management of abnormal screening results

How do the HPV vaccine and the test fit together?

The HPV vaccine and the HPV test work together rather than replacing each other. The vaccine protects against the high-risk types that account for around 90 % of cervical cancers and is most effective when given before exposure, while the test detects infection in those already exposed. Importantly, vaccinated women still need screening, because the vaccine does not cover every high-risk type. Thinking of them as partners — prevention plus early detection — is the most accurate way to understand how cervical cancer is being pushed toward elimination.

How are abnormal results and precancer treated?

When screening and colposcopy confirm a precancerous change, treatment is usually straightforward and preserves the cervix. The most common approach removes or destroys the small area of abnormal tissue — for example with a LEEP (loop excision) or cone biopsy — in a short procedure, and this is highly effective at preventing progression. We favour the least extensive treatment that fully addresses the abnormality, to protect both the cervix and future fertility. Regular follow-up afterwards confirms the change has resolved and catches any recurrence early.

What is our approach to HPV testing and results?

Our approach is to test appropriately, explain results honestly, and follow up calmly without overtreating. We screen according to your age and risk rather than testing for its own sake, and when a result is positive we take the time to explain what it means and what it does not. Where follow-up such as colposcopy or treatment of precancer is needed, we choose the least invasive option that fully addresses the problem and protects your fertility. We see our job as removing fear with facts and clear steps, so you feel informed rather than alarmed at every stage.

Why does experienced gynaecological care matter here?

Reading an HPV result well and managing any abnormality safely depends on experience, because the right next step is rarely one-size-fits-all. Associate Professor Dr. Cengiz Andan brings 18 years of practice, more than 2,000 laparoscopic operations and over 500 endometriosis surgeries, with broad experience in colposcopy and the treatment of cervical changes. That experience helps judge when to watch and when to act, and when treatment is needed it can be kept conservative, with a complication rate kept low, at around 2 %. We are clear, too, that screening reduces risk rather than removing it entirely, and that follow-up matters.

Your home country or Turkey — what's the difference?

For HPV testing and follow-up, the difference between your home country and Turkey is mainly access and cost, not the quality of the test or the care. The same validated HPV tests and the same international guidelines are used in Turkey, so the standard is comparable; the lower price reflects local costs, not a lower standard. For many international patients the practical value is prompt testing, an unhurried explanation of a worrying result, and the option to have any follow-up done quickly during one visit.

How does the process and follow-up work from abroad?

For patients abroad, the process usually begins with an online review of your history and any previous results, and is completed in a short visit if testing or treatment is needed. You first discuss your situation and any worrying result online, and a plan is agreed; the test itself takes minutes, and colposcopy or treatment of precancer can often be arranged within the same short stay. Results and reports are prepared so your own doctor can continue your care, and follow-up can be coordinated remotely afterwards. Many questions about a result can simply be answered online without travel at all.